Molecules 2010, 15
8587
J = 8.10 Hz, 2H, NH), 7.81 (d, J = 7.50 Hz, 2H, ArH), 7.45-7.30 (m, 12H, ArH), 7.01-6.96 (m, 2H,
ArH), 5.08 (dd, J = 7.50, 13.50 Hz, 2H, CHNH), 5.02 (t, J = 5.10 Hz, 2H, OH), 3.71-3.65 (m, 4H,
CH2O); 13C-NMR (DMSO): δ 164.5, 140.3, 139.9, 135.4, 133.6, 132.6, 129.5, 128.3, 127.4, 127.4,
127.2, 124.8, 119.9, 64.5, 55.6; Anal. Calcd. for C32H28N2O4 (504.58): C 76.17, H 5.59, N 5.55;
Found: C 76.01, H 5.70, N 5.27.
3.3. The synthesis and characterization of bis(oxazoline) ligands 1a-d
3.3.1. Bis[(S)-4-iso-propyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1a)
MsCl (0.30 g, 2.63 mmol) was slowly added to an ice-cooled solution of the dihydroxydiamide 3a
(0.50 g, 1.15 mmol) and Et3N (4 mL, 28 mmol) in CH2Cl2 (20 mL). The mixture was allowed to warm
to room temperature and stirred for 12 h. The mixture was washed with water (2 × 5 mL). The organic
layer was dried over anhydrous Na2SO4 and concentrated to dryness in vacuo, the residue was purified
by flash chromatography on silica gel (ethyl acetate/petroleum ether, 1/1, v/v) to afford 1a as a yellow
25
solid. Yield: 0.36 g (78%); m.p. 163~164.5 °C; [α]D = -88.6 (c = 0.50, CH2Cl2). IR (cm-1): 2956,
1
2874, 1652, 1609, 1481, 1447, 1370, 1016, 946, 785, 732; H-NMR (CDCl3): δ 7.73 (d,
J = 7.46 Hz, 2H), 7.58 (d, J = 7.50Hz, 2H), 7.35-7.30 (m, 2H, ArH), 7.21-7.15 (m, 2H, ArH),
4.51-4.46 (m, 2H, CHN=), 4.26-4.15 (m, 4H, CH2O), 1.96 (t, J = 6.63 Hz, 2H, CHMe), 1.06 (d,
13
J = 6.75 Hz, 6H, CH3), 0.99 (d, J = 6.75 Hz, 6H, CH3); C-NMR (CDCl3): δ 161.3, 144.8, 141.5,
136.5, 130.2, 127.2, 125.9, 119.5, 115.1, 73.4, 70.3, 32.7, 19.1, 18.3; Anal. Calcd. for C26H28N2O2
(400.51): C 77.97, H 7.05, N 6.99; Found: C 77.98, H 7.24, N 7.07.
3.3.2. Bis[(S)-4-iso-butyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1b)
Prepared according to procedure 3.3.1, starting from 3b (0.5 g, 1.08 mmol) and MsCl (0.28 g,
2.46 mmol) in CH2Cl2 (15.0 mL); yellow solid; yield: 0.39 g (84 %); m.p. 67.0~68.5 °C; [α]D25 = -88.8
(c = 0.25, CH2Cl2). IR (cm-1): 2955, 1648, 1468, 1449, 1368, 1276, 1152, 1040, 1003, 938, 786, 728;
1H-NMR (CDCl3): δ 7.75 (d, J = 7.80 Hz, 2H, ArH), 7.58 (d, J = 7.50 Hz, 2H, ArH), 7.36-7.30 (m, 2H,
ArH), 7.21-7.16 (m, 2H, ArH), 4.59-4.53 (dd, J = 7.80, 9.60 Hz, 2H, CH2O), 4.48-4.40 (m, 2H,
CHN=), 4.05 (t, J = 7.80 Hz, 2H, CH2O), 1.90-1.78 (m, 4H, CH2), 1.52-1.41 (m, 2H, CHMe2), 0.99 (t,
13
J = 6.0 Hz, 12H, CH3); C-NMR (CDCl3): δ 161.1, 144.8, 141.5, 136.4, 130.2, 127.1, 125.9, 119.4,
114.9, 73.2, 70.3, 65.6, 44.9, 25.3, 22.6, 22.6; Anal. Calcd. for C28H32N2O2 (428.57): C 78.47, H 7.53,
N 6.54. Found: C 78.66, H 7.75, N 6.57.
3.3.3. Bis[(S)-4-benzyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1c)
Prepared according to the procedure 3.3.1, starting from 3c (0.50 g, 0.94 mmol) and MsCl (0.25 g,
2.19 mmol) in CH2Cl2 (15.0 mL); yellow solid; yield: 0.36g (77%); m.p. 120.0~122.0 °C;
25
[α]D = -108.8 (c = 0.25, CH2Cl2). IR (cm-1): 2957,1649, 1614, 1496, 1449, 1309, 1228, 1147, 1018,
1
977, 783, 728, 700; H-NMR (CDCl3): δ 7.61 (d, J = 7.84 Hz, 2H), 7.56 (d, J = 7.23 Hz, 2H, ArH),
7.35-7.21 (m, 12H, ArH), 7.16-7.11(m, 2H), 4.79-4.68 (m, 4H, CHN=), 4.45(t, J = 8.74 Hz, 2H,
CH2O), 4.18 (t, J = 8.44 Hz, 2H, CH2O), 3.32 (dd, J = 5.18, 13.81Hz, 2H, CH2Ph), 2.90 (dd, J = 8.60,
13
13.80 Hz, 2H, CH2Ph); C-NMR (CDCl3): δ 162.0, 145.4, 141.6, 137.6, 136.4, 130.4, 129.4, 128.6,